Ana Teixeira-Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Teixeira-Silva has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Ildar Gabaev
Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, United Kingdom
4 shared publications- Thomas W. M. Crozier
Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK
4 shared publications - Edward J. D. Greenwood
Department of Medicine, University of Cambridge, Cambridge, United Kingdom
3 shared publications - Julien Hardy
Aix Marseille Univ, Marseille Canc Res Ctr CRCM, Inst Paoli Calmettes, UMR7258 CNRS,U1068 Inserm, F-13009 Marseille, France
3 shared publications Karine Fréon
Institut Curie, PSL Research University, UMR3348, Orsay, France
3 shared publications- Paul Joseph Lehner
Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK
3 shared publications
Latest Publications
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Ku orchestrates resection at terminally-arrested replication forks, and stimulates fork restart by homologous recombination
Ku coordonne la résection des fourches de réplication bloquées, et stimule le redémarrage des fourches par la recombinaison homologue: Au cours de la réplication de l’ADN, les cellules rencontrent régulièrement des obstacles d’origine endogène et exogène qui peuvent mettre en péril la réplication des génomes et menacer la duplication et ségrégation des chromosomes en mitose. La Recombinaison Homologue (RH) a un rôle bien caractérisé dans la réparation des cassures double-brin. Par contre, son rôle dans la protection et le redémarrage des fourches de réplication est moins bien caractérisé. Il a été montré par l’équipe que le redémarrage des fourches bloquées par la RH dépend de la formation d’ADN simple-brin et pas d’une cassure double-brin.Afin d’étudier les mécanismes par lesquels la RH contribue au sauvetage des fourches de réplication bloquées, un système permettant de bloquer localement la progression d’une seule fourche de réplication a été utilisé. Cet essai génétique a permis de montrer que le redémarrage de fourches bloquées par la RH est associé à une synthèse d’ADN fautive suite à des événements de glissement de la polymérase au niveau de micro-homologies. Un marqueur génétique a été associé à la barrière de réplication afin de mesurer l’efficacité de redémarrage des fourches bloquées et d’étudier l’étape de résection (i.e formation de l’ADN simple brin) dans différents fonds génétiques.Dans ce travail, le rôle de facteurs impliqués dans la résection a été étudié dans le contexte d’un blocage de fourche de réplication. Comme pour la réparation de cassures double-brin, la résection des fourches bloquées se fait en deux étapes : résection initiale et extensive. La résection initiale, de faible portée, dépend du complexe MRN (Mre11/Rad50/Nbs1) et Ctp1. A cette étape, la dégradation de l’ADN néosynthétisé se fait sur une distance de 110 bp. Cette résection est suffisante pour permettre de recruter les facteurs de la RH, mais est aussi nécessaire pour que les fourches continuent à être résectées. L’absence de MRN et/ou Ctp1 conduit à un défaut de redémarrage. La résection extensive, qui expose de l’ADN simple brin sur une distance de 0,8 à 1Kb, est largement dépendante de la nucléase Exo1. Contrairement à la résection initiale, la résection extensive n’est pas critique pour le redémarrage des fourches par la RH.De façon intéressante, le facteur Ku, connu pour être impliqué dans la jonction d’extrémités non-homologue, a un rôle dans le contrôle de la résection initiale et extensive et dans l’optimisation du redémarrage des fourches bloquées. Plus précisément, en absence de Ku, de l’ADN simple-brin s’accumule en amont des fourches bloquées, et la dynamique de redémarrage est affaiblie, mais pas abolie. Globalement, ces résultats clarifient une étape cruciale dans le redémarrage des fourches par la RH : la résection.
- 2 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Ku orchestrates resection at terminally-arrested replication forks, and stimulates fork restart by homologous recombination
Ku coordonne la résection des fourches de réplication bloquées, et stimule le redémarrage des fourches par la recombinaison homologue: Au cours de la réplication de l’ADN, les cellules rencontrent régulièrement des obstacles d’origine endogène et exogène qui peuvent mettre en péril la réplication des génomes et menacer la duplication et ségrégation des chromosomes en mitose. La Recombinaison Homologue (RH) a un rôle bien caractérisé dans la réparation des cassures double-brin. Par contre, son rôle dans la protection et le redémarrage des fourches de réplication est moins bien caractérisé. Il a été montré par l’équipe que le redémarrage des fourches bloquées par la RH dépend de la formation d’ADN simple-brin et pas d’une cassure double-brin.Afin d’étudier les mécanismes par lesquels la RH contribue au sauvetage des fourches de réplication bloquées, un système permettant de bloquer localement la progression d’une seule fourche de réplication a été utilisé. Cet essai génétique a permis de montrer que le redémarrage de fourches bloquées par la RH est associé à une synthèse d’ADN fautive suite à des événements de glissement de la polymérase au niveau de micro-homologies. Un marqueur génétique a été associé à la barrière de réplication afin de mesurer l’efficacité de redémarrage des fourches bloquées et d’étudier l’étape de résection (i.e formation de l’ADN simple brin) dans différents fonds génétiques.Dans ce travail, le rôle de facteurs impliqués dans la résection a été étudié dans le contexte d’un blocage de fourche de réplication. Comme pour la réparation de cassures double-brin, la résection des fourches bloquées se fait en deux étapes : résection initiale et extensive. La résection initiale, de faible portée, dépend du complexe MRN (Mre11/Rad50/Nbs1) et Ctp1. A cette étape, la dégradation de l’ADN néosynthétisé se fait sur une distance de 110 bp. Cette résection est suffisante pour permettre de recruter les facteurs de la RH, mais est aussi nécessaire pour que les fourches continuent à être résectées. L’absence de MRN et/ou Ctp1 conduit à un défaut de redémarrage. La résection extensive, qui expose de l’ADN simple brin sur une distance de 0,8 à 1Kb, est largement dépendante de la nucléase Exo1. Contrairement à la résection initiale, la résection extensive n’est pas critique pour le redémarrage des fourches par la RH.De façon intéressante, le facteur Ku, connu pour être impliqué dans la jonction d’extrémités non-homologue, a un rôle dans le contrôle de la résection initiale et extensive et dans l’optimisation du redémarrage des fourches bloquées. Plus précisément, en absence de Ku, de l’ADN simple-brin s’accumule en amont des fourches bloquées, et la dynamique de redémarrage est affaiblie, mais pas abolie. Globalement, ces résultats clarifient une étape cruciale dans le redémarrage des fourches par la RH : la résection.
- Open Access
- 3 February 2023
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 21 (2) , e3001959
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19.
- 3 February 2023
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 21 (2) , e3001959
Open AccessLRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19.
- Open Access
- 7 September 2022
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 7, 224
Quantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion
Background: Quantitative proteomics is able to provide a comprehensive, unbiased description of changes to cells caused by viral infection, but interpretation may be complicated by differential changes in infected and uninfected ‘bystander’ cells, or the use of non-physiological cellular models. Methods: In this paper, we use fluorescence-activated cell sorting (FACS) and quantitative proteomics to analyse cell-autonomous changes caused by authentic SARS-CoV-2 infection of respiratory epithelial cells, the main target of viral infection in vivo. First, we determine the relative abundance of proteins in primary human airway epithelial cells differentiated at the air-liquid interface (basal, secretory and ciliated cells). Next, we specifically characterise changes caused by SARS-CoV-2 infection of ciliated cells. Finally, we compare temporal proteomic changes in infected and uninfected ‘bystander’ Calu-3 lung epithelial cells and compare infection with B.29 and B.1.1.7 (Alpha) variants. Results: Amongst 5,709 quantified proteins in primary human airway ciliated cells, the abundance of 226 changed significantly in the presence of SARS-CoV-2 infection (q 1.5-fold). Notably, viral replication proceeded without inducing a type-I interferon response. Amongst 6,996 quantified proteins in Calu-3 cells, the abundance of 645 proteins changed significantly in the presence of SARS-CoV-2 infection (q < 0.05 and > 1.5-fold). In contrast to the primary cell model, a clear type I interferon (IFN) response was observed. Nonetheless, induction of IFN-inducible proteins was markedly attenuated in infected cells, compared with uninfected ‘bystander’ cells. Infection with B.29 and B.1.1.7 (Alpha) variants gave similar results. Conclusions: Taken together, our data provide a detailed proteomic map of changes in SARS-CoV-2-infected respiratory epithelial cells in two widely used, physiologically relevant models of infection. As well as identifying dysregulated cellular proteins and processes, the effectiveness of strategies employed by SARS-CoV-2 to avoid the type I IFN response is illustrated in both models.
- 7 September 2022
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 7, 224
Open AccessQuantitative proteomic analysis of SARS-CoV-2 infection of primary human airway ciliated cells and lung epithelial cells demonstrates the effectiveness of SARS-CoV-2 innate immune evasion
Background: Quantitative proteomics is able to provide a comprehensive, unbiased description of changes to cells caused by viral infection, but interpretation may be complicated by differential changes in infected and uninfected ‘bystander’ cells, or the use of non-physiological cellular models. Methods: In this paper, we use fluorescence-activated cell sorting (FACS) and quantitative proteomics to analyse cell-autonomous changes caused by authentic SARS-CoV-2 infection of respiratory epithelial cells, the main target of viral infection in vivo. First, we determine the relative abundance of proteins in primary human airway epithelial cells differentiated at the air-liquid interface (basal, secretory and ciliated cells). Next, we specifically characterise changes caused by SARS-CoV-2 infection of ciliated cells. Finally, we compare temporal proteomic changes in infected and uninfected ‘bystander’ Calu-3 lung epithelial cells and compare infection with B.29 and B.1.1.7 (Alpha) variants. Results: Amongst 5,709 quantified proteins in primary human airway ciliated cells, the abundance of 226 changed significantly in the presence of SARS-CoV-2 infection (q 1.5-fold). Notably, viral replication proceeded without inducing a type-I interferon response. Amongst 6,996 quantified proteins in Calu-3 cells, the abundance of 645 proteins changed significantly in the presence of SARS-CoV-2 infection (q < 0.05 and > 1.5-fold). In contrast to the primary cell model, a clear type I interferon (IFN) response was observed. Nonetheless, induction of IFN-inducible proteins was markedly attenuated in infected cells, compared with uninfected ‘bystander’ cells. Infection with B.29 and B.1.1.7 (Alpha) variants gave similar results. Conclusions: Taken together, our data provide a detailed proteomic map of changes in SARS-CoV-2-infected respiratory epithelial cells in two widely used, physiologically relevant models of infection. As well as identifying dysregulated cellular proteins and processes, the effectiveness of strategies employed by SARS-CoV-2 to avoid the type I IFN response is illustrated in both models.
- Open Access
- 10 February 2022
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (2) , e1010265
A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection
Efforts to define serological correlates of protection against COVID-19 have been hampered by the lack of a simple, scalable, standardised assay for SARS-CoV-2 infection and antibody neutralisation. Plaque assays remain the gold standard, but are impractical for high-throughput screening. In this study, we show that expression of viral proteases may be used to quantitate infected cells. Our assays exploit the cleavage of specific oligopeptide linkers, leading to the activation of cell-based optical biosensors. First, we characterise these biosensors using recombinant SARS-CoV-2 proteases. Next, we confirm their ability to detect viral protease expression during replication of authentic virus. Finally, we generate reporter cells stably expressing an optimised luciferase-based biosensor, enabling viral infection to be measured within 24 h in a 96- or 384-well plate format, including variants of concern. We have therefore developed a luminescent SARS-CoV-2 reporter cell line, and demonstrated its utility for the relative quantitation of infectious virus and titration of neutralising antibodies.
- 10 February 2022
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 18 (2) , e1010265
Open AccessA protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection
Efforts to define serological correlates of protection against COVID-19 have been hampered by the lack of a simple, scalable, standardised assay for SARS-CoV-2 infection and antibody neutralisation. Plaque assays remain the gold standard, but are impractical for high-throughput screening. In this study, we show that expression of viral proteases may be used to quantitate infected cells. Our assays exploit the cleavage of specific oligopeptide linkers, leading to the activation of cell-based optical biosensors. First, we characterise these biosensors using recombinant SARS-CoV-2 proteases. Next, we confirm their ability to detect viral protease expression during replication of authentic virus. Finally, we generate reporter cells stably expressing an optimised luciferase-based biosensor, enabling viral infection to be measured within 24 h in a 96- or 384-well plate format, including variants of concern. We have therefore developed a luminescent SARS-CoV-2 reporter cell line, and demonstrated its utility for the relative quantitation of infectious virus and titration of neutralising antibodies.
- Open Access
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Summary: The interactions between severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to COVID-19. The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary ACE2 receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was restricted to SARS-CoV-2, suggesting LRRC15 represents a novel class of spike binding interaction. We localized the interaction to the C-terminus of the S1 domain, and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19. In brief: We present evidence from genome-wide screening that the spike protein of SARS-CoV-2 interacts with human cells expressing LRRC15. The interaction is distinct from previously known classes of spike attachment factors, and appears to have emerged recently within the coronavirus family. Although not sufficient for cell invasion, this interaction can modulate viral infection. Our data point to an unappreciated host factor for SARS-CoV-2, with potential relevance to COVID-19. Highlights: - Two systematic cell-based screens for SARS-CoV-2 spike protein binding identify LRRC15 as a human host factor - Interaction with LRRC15 is reproducible in different human cell lines and independent of known glycan or ACE2 binding pathways - The C-terminal S1 domain of SARS-CoV-2 spike binds LRRC15 with sub-micromolar affinity, while related coronavirus spikes do not - LRRC15 is expressed in tissues with high ACE2 levels and may modulate infection
Open AccessLRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Summary: The interactions between severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to COVID-19. The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary ACE2 receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was restricted to SARS-CoV-2, suggesting LRRC15 represents a novel class of spike binding interaction. We localized the interaction to the C-terminus of the S1 domain, and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19. In brief: We present evidence from genome-wide screening that the spike protein of SARS-CoV-2 interacts with human cells expressing LRRC15. The interaction is distinct from previously known classes of spike attachment factors, and appears to have emerged recently within the coronavirus family. Although not sufficient for cell invasion, this interaction can modulate viral infection. Our data point to an unappreciated host factor for SARS-CoV-2, with potential relevance to COVID-19. Highlights: - Two systematic cell-based screens for SARS-CoV-2 spike protein binding identify LRRC15 as a human host factor - Interaction with LRRC15 is reproducible in different human cell lines and independent of known glycan or ACE2 binding pathways - The C-terminal S1 domain of SARS-CoV-2 spike binds LRRC15 with sub-micromolar affinity, while related coronavirus spikes do not - LRRC15 is expressed in tissues with high ACE2 levels and may modulate infection
- Open Access
- 4 October 2019
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 15 (10) , e1008441
Histone deposition promotes recombination-dependent replication at arrested forks
Replication stress poses a serious threat to genome stability. Recombination-Dependent-Replication (RDR) promotes DNA synthesis resumption from arrested forks. Despite the identification of chromatin restoration pathways after DNA repair, crosstalk coupling RDR and chromatin assembly is largely unexplored. The fission yeast Chromatin Assembly Factor-1, CAF-1, is known to promote RDR. Here, we addressed the contribution of histone deposition to RDR. We expressed a mutated histone, H3-H113D, to genetically alter replication-dependent chromatin assembly by destabilizing (H3-H4)2 tetramer. We established that DNA synthesis-dependent histone deposition, by CAF-1 and Asf1, promotes RDR by preventing Rqh1-mediated disassembly of joint-molecules. The recombination factor Rad52 promotes CAF-1 binding to sites of recombination-dependent DNA synthesis, indicating that histone deposition occurs downstream Rad52. Histone deposition and Rqh1 activity act synergistically to promote cell resistance to camptothecin, a topoisomerase I inhibitor that induces replication stress. Moreover, histone deposition favors non conservative recombination events occurring spontaneously in the absence of Rqh1, indicating that the stabilization of joint-molecules by histone deposition also occurs independently of Rqh1 activity. These results indicate that histone deposition plays an active role in promoting RDR, a benefit counterbalanced by stabilizing at-risk joint-molecules for genome stability. DNA replication occurs in the context of DNA packaged into chromatin. At replication fork, the parental chromatin is evicted and re-assembled, together with newly synthetized histones, onto newly replicated DNA thanks to a network of histone chaperones. The progression of replication forks is often interrupted by a plethora of fork obstacles that affect replisome functionality. Such dysfunctional forks are fragile structures prone to chromosomal rearrangements and chromatin changes, leading to human diseases including cancer. Homologous recombination plays a crucial role in the recovery of dysfunctional forks. We have genetically altered the process of histone deposition-coupled to DNA synthesis to interrogate the contribution of chromatin assembly during fork recovery by homologous recombination. We found that histone deposition acts during fork recovery in a manner that recombination structures are protected from disassembly by helicases such as Rqh1. Histone deposition-coupled to fork recovery favors deletion-type recombinant. Chromatin assembly during fork recovery requires only a subset of the histone chaperones normally acting at canonical forks, namely CAF-1 and Asf1. CAF-1 associates to sites of recombination-dependent DNA synthesis during fork recovery. We propose that restarted forks remain coupled to histone deposition, a benefit counterbalanced by the risk to stabilize recombination intermediates detrimental to genome stability.
- 4 October 2019
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 15 (10) , e1008441
Open AccessHistone deposition promotes recombination-dependent replication at arrested forks
Replication stress poses a serious threat to genome stability. Recombination-Dependent-Replication (RDR) promotes DNA synthesis resumption from arrested forks. Despite the identification of chromatin restoration pathways after DNA repair, crosstalk coupling RDR and chromatin assembly is largely unexplored. The fission yeast Chromatin Assembly Factor-1, CAF-1, is known to promote RDR. Here, we addressed the contribution of histone deposition to RDR. We expressed a mutated histone, H3-H113D, to genetically alter replication-dependent chromatin assembly by destabilizing (H3-H4)2 tetramer. We established that DNA synthesis-dependent histone deposition, by CAF-1 and Asf1, promotes RDR by preventing Rqh1-mediated disassembly of joint-molecules. The recombination factor Rad52 promotes CAF-1 binding to sites of recombination-dependent DNA synthesis, indicating that histone deposition occurs downstream Rad52. Histone deposition and Rqh1 activity act synergistically to promote cell resistance to camptothecin, a topoisomerase I inhibitor that induces replication stress. Moreover, histone deposition favors non conservative recombination events occurring spontaneously in the absence of Rqh1, indicating that the stabilization of joint-molecules by histone deposition also occurs independently of Rqh1 activity. These results indicate that histone deposition plays an active role in promoting RDR, a benefit counterbalanced by stabilizing at-risk joint-molecules for genome stability. DNA replication occurs in the context of DNA packaged into chromatin. At replication fork, the parental chromatin is evicted and re-assembled, together with newly synthetized histones, onto newly replicated DNA thanks to a network of histone chaperones. The progression of replication forks is often interrupted by a plethora of fork obstacles that affect replisome functionality. Such dysfunctional forks are fragile structures prone to chromosomal rearrangements and chromatin changes, leading to human diseases including cancer. Homologous recombination plays a crucial role in the recovery of dysfunctional forks. We have genetically altered the process of histone deposition-coupled to DNA synthesis to interrogate the contribution of chromatin assembly during fork recovery by homologous recombination. We found that histone deposition acts during fork recovery in a manner that recombination structures are protected from disassembly by helicases such as Rqh1. Histone deposition-coupled to fork recovery favors deletion-type recombinant. Chromatin assembly during fork recovery requires only a subset of the histone chaperones normally acting at canonical forks, namely CAF-1 and Asf1. CAF-1 associates to sites of recombination-dependent DNA synthesis during fork recovery. We propose that restarted forks remain coupled to histone deposition, a benefit counterbalanced by the risk to stabilize recombination intermediates detrimental to genome stability.
- Open Access
- 7 December 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-14
The end-joining factor Ku acts in the end-resection of double strand break-free arrested replication forks
Replication requires homologous recombination (HR) to stabilize and restart terminally arrested forks. HR-mediated fork processing requires single stranded DNA (ssDNA) gaps and not necessarily double strand breaks. We used genetic and molecular assays to investigate fork-resection and restart at dysfunctional, unbroken forks in Schizosaccharomyces pombe. Here, we report that fork-resection is a two-step process regulated by the non-homologous end joining factor Ku. An initial resection mediated by MRN-Ctp1 removes Ku from terminally arrested forks, generating ~110 bp sized gaps obligatory for subsequent Exo1-mediated long-range resection and replication restart. The mere lack of Ku impacts the processing of arrested forks, leading to an extensive resection, a reduced recruitment of RPA and Rad51 and a slower fork-restart process. We propose that terminally arrested forks undergo fork reversal, providing a single DNA end for Ku binding. We uncover a role for Ku in regulating end-resection of unbroken forks and in fine-tuning HR-mediated replication restart.
- 7 December 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-14
Open AccessThe end-joining factor Ku acts in the end-resection of double strand break-free arrested replication forks
Replication requires homologous recombination (HR) to stabilize and restart terminally arrested forks. HR-mediated fork processing requires single stranded DNA (ssDNA) gaps and not necessarily double strand breaks. We used genetic and molecular assays to investigate fork-resection and restart at dysfunctional, unbroken forks in Schizosaccharomyces pombe. Here, we report that fork-resection is a two-step process regulated by the non-homologous end joining factor Ku. An initial resection mediated by MRN-Ctp1 removes Ku from terminally arrested forks, generating ~110 bp sized gaps obligatory for subsequent Exo1-mediated long-range resection and replication restart. The mere lack of Ku impacts the processing of arrested forks, leading to an extensive resection, a reduced recruitment of RPA and Rad51 and a slower fork-restart process. We propose that terminally arrested forks undergo fork reversal, providing a single DNA end for Ku binding. We uncover a role for Ku in regulating end-resection of unbroken forks and in fine-tuning HR-mediated replication restart.
- 1 May 2017
- Published by Elsevier in Molecular Cell
- Vol. 66 (3) , 398-410.e4
Unprotected Replication Forks Are Converted into Mitotic Sister Chromatid Bridges
- 1 May 2017
- Published by Elsevier in Molecular Cell
- Vol. 66 (3) , 398-410.e4
Unprotected Replication Forks Are Converted into Mitotic Sister Chromatid Bridges
- Open Access
- 4 June 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e64884
The Role of Recombination in the Origin and Evolution of Alu Subfamilies
Alus are the most abundant and successful short interspersed nuclear elements found in primate genomes. In humans, they represent about 10% of the genome, although few are retrotransposition-competent and are clustered into subfamilies according to the source gene from which they evolved. Recombination between them can lead to genomic rearrangements of clinical and evolutionary significance. In this study, we have addressed the role of recombination in the origin of chimeric Alu source genes by the analysis of all known consensus sequences of human Alus. From the allelic diversity of Alu consensus sequences, validated in extant elements resulting from whole genome searches, distinct events of recombination were detected in the origin of particular subfamilies of AluS and AluY source genes. These results demonstrate that at least two subfamilies are likely to have emerged from ectopic Alu-Alu recombination, which stimulates further research regarding the potential of chimeric active Alus to punctuate the genome.
- 4 June 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e64884
Open AccessThe Role of Recombination in the Origin and Evolution of Alu Subfamilies
Alus are the most abundant and successful short interspersed nuclear elements found in primate genomes. In humans, they represent about 10% of the genome, although few are retrotransposition-competent and are clustered into subfamilies according to the source gene from which they evolved. Recombination between them can lead to genomic rearrangements of clinical and evolutionary significance. In this study, we have addressed the role of recombination in the origin of chimeric Alu source genes by the analysis of all known consensus sequences of human Alus. From the allelic diversity of Alu consensus sequences, validated in extant elements resulting from whole genome searches, distinct events of recombination were detected in the origin of particular subfamilies of AluS and AluY source genes. These results demonstrate that at least two subfamilies are likely to have emerged from ectopic Alu-Alu recombination, which stimulates further research regarding the potential of chimeric active Alus to punctuate the genome.